To examine whether genetic variants in miRNA genes might be able to explain some of the unidentified genetic predisposition in familial ovarian cancer, we screened genetic variants in select miRNA genes in ovarian cancer patients who are non-carriers of any known BRCA1/2 or MMR gene mutations. This evidence concerns the gene BRCA1 and ovarian carcinoma.